Extract notice to the Minister
Ilumya (psoriasis plaques)
Common name / Subject : tildrakizumab
Name of the manufacturer : Sun Pharma
Form : Sol. Inj. S. C. (ser)
Dosage : 100 mg/ml (1 ml)
Name of the manufacturer : Sun Pharma
Form : Sol. Inj. S. C. (ser)
Dosage : 100 mg/ml (1 ml)
Indication : Traitement du psoriasis en plaques
INESSS' Recommendation
Refus d'inscription
Minister's decisions
Ne pas inscrire aux listes des médicaments (2021-09-29)
Evaluation published on September 01, 2021